Research Article: Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study
Introduction:
Age-related macular degeneration (AMD) is one of the major causes of irreversible central visual impairment and is responsible for .% of all cases of blindness worldwide. – Globally, the number is estimated to rise to nearly million by the year . In India, early AMD and the resulting vision loss are a growing concern, with reports of a prevalence ranging from .% to .%, and age is found to be affecting the prevalence. The wet or neovascular AMD (nAMD), though less frequent, has been associated with % of cases of…
Read more